BTIG Downgrades Akoya Biosciences Inc (AKYA) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Morgan Stanley Downgrades Akoya Biosciences Inc (AKYA) to Equalweight
August 6, 2024 12:06 PM EDTMorgan Stanley analyst Tejas Savant downgraded Akoya Biosciences Inc (NASDAQ: AKYA) from Overweight to Equalweight with a price target of $3.00 (from $4.00).
The analyst comments "Guide lowered again despite in-line qtr as placements rebound falls short of expectations on weak capital... More
JPMorgan Downgrades Akoya Biosciences Inc (AKYA) to Neutral
August 6, 2024 2:54 AM EDTJPMorgan analyst Rachel Vatnsdal downgraded Akoya Biosciences Inc (NASDAQ: AKYA) from Overweight to Neutral.
The analyst comments: "This afternoon, Akoya (AKYA) reported 2Q results with revenue of $23.2M (roughly in line with the Street of $23.6M), driven by 51 instrument placements (bringing the total installed base to 1,264 vs. 1,213 in 1Q, +4% q/q). Looking ahead, the... More
Akoya (AKYA) Reports In-Line Q2 EPS, provides guidance
August 5, 2024 4:09 PM EDTAkoya (NASDAQ: AKYA) reported Q2 EPS of ($0.27), in-line with the analyst estimate of ($0.27). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $23.55 million.
GUIDANCE:
Akoya sees FY2024 revenue of $96-104 million, versus the consensus of $103.2... More
